Digestive Diseases Week conference – Chicago, May 6-9, 2023.

Jos Houbiers, CMO of Calypso Biotech, gives an oral presentation entitled: “Interim resuts from a first-in-human study of the anti-IL-15 antibody CALY-002 for treating Celiac Disease and Eosinophilic Esophagitis”.